Virtual
The Emerging Role of Antibody-Drug Conjugates in Perioperative Treatment of MIBC
Hosted by Medscape, LLC
May 6, 2026 – Jun 3, 2026 Online / Virtual
About This Event
This live course examines the scientific rationale and emerging clinical evidence for incorporating antibody-drug conjugates (ADCs) into the multidisciplinary perioperative management of patients with muscle-invasive bladder cancer (MIBC). Participants will evaluate current evidence and treatment strategies for this patient population.
Sign in to unlock everything networkED.global adds to this event
We enrich every event with details scattered across the web — organized, verified, in one place:
- Earning CE? CE credits, accreditation, and which licenses it counts toward — tracked automatically.
- Speaking? Call-for-proposal deadlines and submission details.
- Exhibiting or sponsoring? Exhibit and sponsorship opportunities.
- Hosting events? Be connected directly to your target audiences.
Plus full agenda, pricing, registration, contacts, and topics covered.